2014 Q4 Form 10-Q Financial Statement

#000091060614000033 Filed on November 04, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $136.2M $133.6M $120.3M
YoY Change 8.09% 11.04% 5.76%
Cost Of Revenue $34.10M $33.00M $30.10M
YoY Change 8.25% 9.63% 4.88%
Gross Profit $102.0M $100.6M $90.20M
YoY Change 14.61% 11.53% 3.8%
Gross Profit Margin 74.89% 75.3% 74.97%
Selling, General & Admin $16.40M $14.50M $15.00M
YoY Change 23.31% -3.33% -3.85%
% of Gross Profit 16.08% 14.41% 16.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.40M $36.50M $33.40M
YoY Change 4.18% 9.28% 10.96%
% of Gross Profit 36.67% 36.28% 37.03%
Operating Expenses $56.60M $52.90M $48.70M
YoY Change 9.27% 8.62% 7.51%
Operating Profit $45.40M $47.70M $41.50M
YoY Change 22.04% 14.94% -0.24%
Interest Expense $8.400M -$21.80M -$12.50M
YoY Change -144.68% 74.4% -41.31%
% of Operating Profit 18.5% -45.7% -30.12%
Other Income/Expense, Net
YoY Change
Pretax Income $52.70M $25.90M $23.00M
YoY Change 184.86% 12.61% 25.68%
Income Tax -$1.000M $1.180M $0.00
% Of Pretax Income -1.9% 4.56% 0.0%
Net Earnings $53.30M $25.70M $40.20M
YoY Change 3.09% -36.07% 108.29%
Net Earnings / Revenue 39.13% 19.24% 33.41%
Basic Earnings Per Share $0.79 $0.52 $0.38
Diluted Earnings Per Share $0.79 $0.52 $0.38
COMMON SHARES
Basic Shares Outstanding 93.24M shares 92.36M shares 92.29M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $114.0M $101.0M $63.00M
YoY Change 40.74% 60.32% 200.0%
Cash & Equivalents $114.0M $101.0M $63.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $12.00M $11.00M
Prepaid Expenses
Receivables $31.00M $26.00M $23.00M
Other Receivables $56.00M $55.00M $51.00M
Total Short-Term Assets $201.0M $194.0M $148.0M
YoY Change 27.22% 31.08% 51.02%
LONG-TERM ASSETS
Property, Plant & Equipment $3.476B $3.391B $3.125B
YoY Change 9.24% 8.51% 2.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $361.0M $356.0M $440.0M
YoY Change -6.48% -19.09% -6.98%
Other Assets $80.00M $82.00M $75.00M
YoY Change 1.27% 9.33% 1.35%
Total Long-Term Assets $3.996B $3.934B $3.749B
YoY Change 6.39% 4.93% 1.32%
TOTAL ASSETS
Total Short-Term Assets $201.0M $194.0M $148.0M
Total Long-Term Assets $3.996B $3.934B $3.749B
Total Assets $4.197B $4.128B $3.897B
YoY Change 7.23% 5.93% 2.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $181.0M $174.0M $147.0M
YoY Change 23.13% 18.37% 13.95%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $207.0M $199.0M $169.0M
YoY Change 21.05% 17.75% 18.18%
LONG-TERM LIABILITIES
Long-Term Debt $2.021B $2.023B $1.864B
YoY Change 8.95% 8.53% 2.36%
Other Long-Term Liabilities $32.00M $32.00M $25.00M
YoY Change 18.52% 28.0% 31.58%
Total Long-Term Liabilities $2.053B $2.055B $1.889B
YoY Change 9.09% 8.79% 2.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $207.0M $199.0M $169.0M
Total Long-Term Liabilities $2.053B $2.055B $1.889B
Total Liabilities $2.291B $2.283B $2.072B
YoY Change 10.68% 10.18% 3.65%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.907B $1.845B $1.825B
YoY Change
Total Liabilities & Shareholders Equity $4.197B $4.128B $3.897B
YoY Change 7.23% 5.93% 2.61%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $53.30M $25.70M $40.20M
YoY Change 3.09% -36.07% 108.29%
Depreciation, Depletion And Amortization $37.40M $36.50M $33.40M
YoY Change 4.18% 9.28% 10.96%
Cash From Operating Activities $59.90M $98.20M $91.30M
YoY Change 19.56% 7.56% 7.67%
INVESTING ACTIVITIES
Capital Expenditures -$109.3M -$87.10M -$81.00M
YoY Change -17.26% 7.53% -15.01%
Acquisitions
YoY Change
Other Investing Activities $85.30M $63.40M $72.30M
YoY Change -44.1% -12.31% -74.49%
Cash From Investing Activities -$24.00M -$23.70M -$8.700M
YoY Change -216.5% 172.41% -104.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00M $1.568M
YoY Change 3088.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -22.90M -10.60M -79.00M
YoY Change -56.63% -86.58% -71.24%
NET CHANGE
Cash From Operating Activities 59.90M 98.20M 91.30M
Cash From Investing Activities -24.00M -23.70M -8.700M
Cash From Financing Activities -22.90M -10.60M -79.00M
Net Change In Cash 13.00M 63.90M 3.600M
YoY Change -27.37% 1675.0% -311.76%
FREE CASH FLOW
Cash From Operating Activities $59.90M $98.20M $91.30M
Capital Expenditures -$109.3M -$87.10M -$81.00M
Free Cash Flow $169.2M $185.3M $172.3M
YoY Change -7.14% 7.54% -4.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-8700000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.3875
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
CY2013Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
26100000 USD
CY2014Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
26800000 USD
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2217000 USD
CY2013Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-2366000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-6966000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-7098000 USD
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
CY2013Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
-3000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1567000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
620000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2026000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
615000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
22225000 USD
us-gaap Payments For Commissions
PaymentsForCommissions
695000 USD
us-gaap Payments For Commissions
PaymentsForCommissions
1520000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-3651000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-28603000 USD
CY2013Q3 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
11834000 USD
CY2014Q3 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
16748000 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
29598000 USD
CY2014Q3 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
27558000 USD
CY2013Q3 us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
16108000 USD
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
29235000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1180000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1546000 USD
us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0 USD
CY2014Q3 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
1180000 USD
us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
1546000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
0 USD
CY2013Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
19300000 USD
CY2014Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
5900000 USD
CY2014Q3 us-gaap Notes Payable
NotesPayable
1948243000 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
1779697000 USD
CY2013Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11960000 USD
CY2014Q3 us-gaap Notes Receivable Net
NotesReceivableNet
12132000 USD
us-gaap Operations Commenced Date1
OperationsCommencedDate1
1993-12-31
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
521000 USD
CY2013Q3 us-gaap Payments For Commissions
PaymentsForCommissions
24000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
69000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
40600000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
217599000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
49995000 USD
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1568000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
101342000 USD
us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
62788000 USD
CY2014Q3 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
55569000 USD
CY2013Q3 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
48999000 USD
us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
131363000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6885000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2350000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9227000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3067000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1899000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
872000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
30000 shares
CY2014Q3 us-gaap Unsecured Debt
UnsecuredDebt
75000000 USD
CY2013Q4 us-gaap Unsecured Debt
UnsecuredDebt
75000000 USD
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
159229 shares
CY2013Q3 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
167649 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
173946 shares
CY2014Q3 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
158920 shares
CY2013Q4 reg Acquired Finite Lived Intangible Liability Amount
AcquiredFiniteLivedIntangibleLiabilityAmount
7929000 USD
CY2014Q3 reg Acquired Finite Lived Intangible Liability Amount
AcquiredFiniteLivedIntangibleLiabilityAmount
9236000 USD
CY2013Q4 reg Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Debt Assumed Netof Premiums
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebtAssumedNetofPremiums
7496000 USD
CY2014Q3 reg Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Debt Assumed Netof Premiums
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebtAssumedNetofPremiums
78049000 USD
CY2014Q3 reg Equity Issuances Amount Available For Issuance
EquityIssuancesAmountAvailableForIssuance
150000000 USD
CY2014Q3 reg Letters Of Credit Maximum Borrowing Capacity Under Line
LettersOfCreditMaximumBorrowingCapacityUnderLine
80000000 USD
reg Weighted Average Price Per Share
WeightedAveragePricePerShare
53.35
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
CY2014Q3 reg Total Longterm Debtand Lineof Credits
TotalLongtermDebtandLineofCredits
2023243000 USD
CY2013Q4 reg Total Longterm Debtand Lineof Credits
TotalLongtermDebtandLineofCredits
1854697000 USD
reg Weighted Average Price Per Share
WeightedAveragePricePerShare
57.35
CY2013Q3 reg Weighted Average Price Per Share
WeightedAveragePricePerShare
52.28
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000910606
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
93243831 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
REGENCY CENTERS CORP
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes

Files In Submission

Name View Source Status
0000910606-14-000033-index-headers.html Edgar Link pending
0000910606-14-000033-index.html Edgar Link pending
0000910606-14-000033.txt Edgar Link pending
0000910606-14-000033-xbrl.zip Edgar Link pending
ex-311093014.htm Edgar Link pending
ex-312093014.htm Edgar Link pending
ex-313093014.htm Edgar Link pending
ex-314093014.htm Edgar Link pending
ex-321093014.htm Edgar Link pending
ex-322093014.htm Edgar Link pending
ex-323093014.htm Edgar Link pending
ex-324093014.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
reg-20140930.xml Edgar Link completed
reg-20140930.xsd Edgar Link pending
reg-20140930_cal.xml Edgar Link unprocessable
reg-20140930_def.xml Edgar Link unprocessable
reg-20140930_lab.xml Edgar Link unprocessable
reg-20140930_pre.xml Edgar Link unprocessable
reg10-q093014.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending